Skip to Main content Skip to Navigation
Journal articles

Pivotal role of NAMPT in the switch of melanoma cells toward an invasive and drug-resistant phenotype

Abstract : In BRAFV600E melanoma cells, a global metabolomic analysis discloses a decrease in nicotinamide adenine dinucleotide (NAD+) levels upon PLX4032 treatment that is conveyed by a STAT5 inhibition and a transcriptional regulation of the nicotinamide phosphoribosyltransferase (NAMPT) gene. NAMPT inhibition decreases melanoma cell proliferation both in vitro and in vivo, while forced NAMPT expression renders melanoma cells resistant to PLX4032. NAMPT expression induces transcriptomic and epigenetic reshufflings that steer melanoma cells toward an invasive phenotype associated with resistance to targeted therapies and immunotherapies. Therefore, NAMPT, the key enzyme in the NAD+ salvage pathway, appears as a rational target in targeted therapy-resistant melanoma cells and a key player in phenotypic plasticity of melanoma cells.
Complete list of metadatas

Cited literature [56 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02528273
Contributor : Bertolotto-Ballotti Bertolotto-Ballotti <>
Submitted on : Wednesday, April 1, 2020 - 5:21:15 PM
Last modification on : Tuesday, May 26, 2020 - 6:50:46 PM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : 2020-09-01

Please log in to resquest access to the document

Identifiers

Collections

Citation

Mickaël Ohanna, Mickaël Cerezo, Nicolas Nottet, Karine Bille, Robin Didier, et al.. Pivotal role of NAMPT in the switch of melanoma cells toward an invasive and drug-resistant phenotype. Genes and Development, Cold Spring Harbor Laboratory Press, 2018, 32 (5-6), pp.448-461. ⟨10.1101/gad.305854.117⟩. ⟨inserm-02528273⟩

Share

Metrics

Record views

61